UniProt ID | U2AF4_HUMAN | |
---|---|---|
UniProt AC | Q8WU68 | |
Protein Name | Splicing factor U2AF 26 kDa subunit | |
Gene Name | U2AF1L4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 220 | |
Subcellular Localization | Nucleus . Nucleus speckle . Cytoplasm . Interaction with C1QBP is required for the nuclear translocation. Displays active nucleo-cytoplasmic shuttling. | |
Protein Description | RNA-binding protein that function as a pre-mRNA splicing factor. Plays a critical role in both constitutive and enhancer-dependent splicing by mediating protein-protein interactions and protein-RNA interactions required for accurate 3'-splice site selection. Acts by enhancing the binding of U2AF2 to weak pyrimidine tracts. Also participates in the regulation of alternative pre-mRNA splicing. Activates exon 5 skipping of PTPRC during T-cell activation; an event reversed by GFI1. Binds to RNA at the AG dinucleotide at the 3'-splice site (By similarity). Shows a preference for AGC or AGA (By similarity).. | |
Protein Sequence | MAEYLASIFGTEKDKVNCSFYFKIGVCRHGDRCSRLHNKPTFSQTIVLLNLYRNPQNTAQTADGSHCHVSDVEVQEHYDSFFEEVFTELQEKYGEIEEMNVCDNLGDHLVGNVYVKFRREEDGERAVAELSNRWFNGQAVHGELSPVTDFRESCCRQYEMGECTRGGFCNFMHLRPISQNLQRQLYGRGPRRRSPPRFHTGHHPRERNHRCSPDHWHGRF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEYLASIF ------CHHHHHHHH | 17.72 | - | |
4 | Phosphorylation | ----MAEYLASIFGT ----CHHHHHHHHCC | 9.68 | 25106551 | |
7 | Phosphorylation | -MAEYLASIFGTEKD -CHHHHHHHHCCCCC | 18.82 | 21955146 | |
11 | Phosphorylation | YLASIFGTEKDKVNC HHHHHHCCCCCCCCC | 29.16 | 21955146 | |
13 | Acetylation | ASIFGTEKDKVNCSF HHHHCCCCCCCCCEE | 63.79 | 54427329 | |
13 | Ubiquitination | ASIFGTEKDKVNCSF HHHHCCCCCCCCCEE | 63.79 | 23000965 | |
15 | Sumoylation | IFGTEKDKVNCSFYF HHCCCCCCCCCEEEE | 46.55 | - | |
15 | Ubiquitination | IFGTEKDKVNCSFYF HHCCCCCCCCCEEEE | 46.55 | 23000965 | |
19 | Phosphorylation | EKDKVNCSFYFKIGV CCCCCCCEEEEEEEE | 20.13 | 26055452 | |
21 | Phosphorylation | DKVNCSFYFKIGVCR CCCCCEEEEEEEECC | 6.41 | 28152594 | |
126 | Phosphorylation | REEDGERAVAELSNR EHHCCHHHHHHHHHC | 10.69 | 24719451 | |
126 (in isoform 2) | Phosphorylation | - | 10.69 | 24719451 | |
144 | Phosphorylation | GQAVHGELSPVTDFR CCCCCCCCCCCCCHH | 9.20 | 24719451 | |
144 (in isoform 2) | Phosphorylation | - | 9.20 | 24719451 | |
158 | Phosphorylation | RESCCRQYEMGECTR HHHHCCHHCCCCCCC | 6.63 | 24043423 | |
164 | Phosphorylation | QYEMGECTRGGFCNF HHCCCCCCCCCCCCE | 28.22 | 24043423 | |
165 | Methylation | YEMGECTRGGFCNFM HCCCCCCCCCCCCEE | 55.70 | 58860221 | |
194 | Phosphorylation | GRGPRRRSPPRFHTG CCCCCCCCCCCCCCC | 37.13 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of U2AF4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of U2AF4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of U2AF4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of U2AF4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...